LAUNCHING OF AIOVA START-UP

2019

AIOVA was co-founded in 2019 in Grenoble by Dr. Corinne Ronfort (CEO) and Yahia Chebloune (CSO), AIOVA is a biotechnology company whose ambition is to revolutionize vaccines thanks to its DNA platform. The ultimate goal is to make vaccination accessible to all at a lower cost in conditions of maximum security.


AIOVA benefits from the expertise developed within the PAVAL laboratory (Lentiviral Pathogenesis and Vaccination, INRAE ​​/ Université Grenoble Alpes) led by Dr. Yahia Chebloune, inventor of vaccine technology.

20200320_122230_edited.png

©2020 par Pathogénèse et Vaccinations Lentivirales. Créé avec Wix.com